EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular CarcinomaHoi-Wing Leung, Terence K. Lee|Cancer Research|2021Cited by 130
Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Carmen Leung et al.|Cancer Research|2022Cited by 106
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery PlatformFrank W. Pun, Alex Zhavoronkov, Bonnie Hei Man Liu et al.|Frontiers in Aging Neuroscience|2022Cited by 99
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engineFrank W. Pun, Alex Zhavoronkov, Xi Long et al.|Aging|2022Cited by 82
NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinomaHoi-Wing Leung, Terence K. Lee, Eunice Y. Lau et al.|Cancer Letters|2020Cited by 53